Rating History for Marker Therapeutics (MRKR) by Canaccord

More Stocks Rated by Canaccord | Latest Ratings for MRKR
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
3/5/2025 John Newman New Coverage Buy
(N/A)		 8.00
(N/A)		 1.38
(1.48)		 7.25% Details